Ankyrin is fatty acid acylated in erythrocytes by Staufenbiel, Matthias & Lazarides, Elias
Proc. Nati. Acad. Sci. USA
Vol. 83, pp. 318-322, January 1986
Biochemistry
Ankyrin is fatty acid acylated in erythrocytes
(erythroid development/membrane-skeleton/plasma membrane)
MATTHIAS STAUFENBIEL* AND ELIAS LAZARIDES
Division of Biology, California Institute of Technology, Pasadena, CA 91125
Communicated by Howard C. Berg, September 19, 1985
ABSTRACT Ankyrin is a peripheral membrane protein
that mediates the attachment of the erythrocyte membrane
skeleton to the plasma membrane. We show that [3H~palmitic
acid is incorporated into ankyrin in vivo. The majority of the
3H-labeled fatty acid is covalently bound to the polypeptide, as
it cannot be removed by strong detergents or by chloro-
form/methanol extraction but is labile to alkaline hydrolysis.
The binding of fatty acid occurs predominantly after the
assembly of ankyrin onto the membrane skeleton, since it
continues when protein synthesis is inhibited with emetine.
Fatty acid acylation of ankyrin is constitutive in erythroid cells
throughout chicken embryo development. It also occurs in
mature avian and mammalian erythrocytes suggesting that the
fatty acid bound to ankyrin turns over more rapidly than the
polypeptide. Fatty acid acylation of assembled ankyrin may
modulate the interaction of ankyrin with the plasma mem-
brane. It may also provide a mechanism by which the mem-
brane skeleton influences the organization of the lipid bilayer.
The cytoplasmic surface of the erythrocyte plasma mem-
brane is lined by a protein network that is thought to influence
the shape, elasticity, and stability of the erythrocyte. This
network, known as the membrane skeleton, is based on the
interaction of two principal components, spectrin tetramers
that bind to and crosslink actin oligomers. (The membrane
skeleton or cytoskeleton is the insoluble residue left after
exposure of cells to a buffer containing nonionic detergent.)
The interaction of spectrin and actin is strongly enhanced by
a protein known as protein 4.1. The spectrin-actin network
is attached to the plasma membrane by the protein ankyrin
that binds simultaneously to spectrin and to the cytoplasmic
domain of the transmembrane anion transporter. Spectrin is
additionally linked to the membrane through the binding of
protein 4.1 to glycophorin (for reviews see refs. 1-3). These
linkages between the plasma membrane and the membrane
skeleton are based on the relatively well-characterized inter-
actions among their constituent proteins. Evidence exists
that cytoskeletal proteins may also interact directly with
membrane lipids. Protein 4.1 binds to proteolyzed vesicles
and phosphatidylserine-containing liposomes, and its asso-
ciation with glycophorin occurs only when the latter has
phosphatidylinositol 4,5-bisphosphate associated with it (3).
Protein 4.1 also appears to contain tightly bound fatty acid
(4). In addition several other unidentified membrane proteins
of the erythrocyte are fatty acid acylated (5), a property that
may facilitate their interaction with membrane lipids (for
reviews on fatty acid acylation see refs. 6 and 7).
We report here that ankyrin is the major [3H]palmitic
acid-labeled protein of the erythrocyte membrane skeleton.
The acylation with fatty acid occurs predominantly at the
plasma membrane after assembly of ankyrin onto the mem-
brane skeleton. Palmitic acid is incorporated into ankyrin at
all stages of avian erythroid development examined and is
also attached to ankyrin in adult avian and mammalian
erythrocytes. This suggests that the ankyrin bound fatty acid
turns over more rapidly than the polypeptide. Reversible
attachment of fatty acid to ankyrin may be a means for a
dynamic interaction of this protein with the plasma mem-
brane.
MATERIALS AND METHODS
Preparation and Labeling of Cells. Chicken embryo
erythroid cells were isolated from fertilized eggs at different
stages of development. Blood was collected from the eggs in
minimal essential medium (MEM, GIBCO) after puncturing
a main yolk vein with a needle. Adult erythrocytes were
isolated from blood drawn from a wing vein (chickens) or ear
vein (rabbits) into MEM supplemented with 0.1% heparin
(Sigma). The diluted blood was filtered through glass wool,
and the cells were collected by centrifugation in a clinical
centrifuge. They were washed five times in MEM and any
buffy coat was removed. Cells were labeled separately with
fatty acids or amino acids at 38°C for 4 hr. About 30 ,ul of
packed cells were labeled in 2 ml ofMEM supplemented with
5 mM sodium pyruvate, nonessential amino acids (GIBCO),
0.1 mM of all of the L-amino acids, and 3-10 mCi of
[9,10-3H]palmitic acid (specific activity 30 Ci/mmol; 1 Ci =
37 GBq, New England Nuclear). For labeling with amino
acids cells were incubated in Earles balanced salt solution
(GIBCO) supplemented with 5 mM sodium pyruvate, 1% of
MEM, 1% of nonessential amino acids and 25-150 ,uCi of an
L-14C-labeled amino acid mixture (specific activity 55
mCi/mol atom carbon; (New England Nuclear). After label-
ing, cells were washed once with coldMEM and fractionated.
In some experiments cells were labeled in the presence of a
protein synthesis inhibitor. These cells were preincubated in
MEM supplemented with 50 ,uM emetine for 15 min at 38°C.
They were then pelleted at room temperature, labeled in
either fatty acid or amino acid labeling medium containing 50
,uM emetine, mixed during the washing step after labeling,
and fractionated together. Under the conditions used incor-
poration of radioactive amino acids was inhibited to the same
extent (by more than 90%) in both labeling media (data not
shown).
Cell Fractionation. Chicken erythrocytes were resuspend-
ed in 20 vol of 10 mM Hepes, pH 7.3, 5 mM MgCl2, 5 mM
EGTA, 137mM NaCl, 1% Triton X-100, 1mM aprotinin (Boeh-
ringer Mannheim), 0.1 mM leupeptin (Boehringer Mann-
heim), 1 mM phenylmethylsulfonyl fluoride (PMSF), incu-
bated for 3 min on ice, and resulting structures were pelleted
in a clinical centrifuge for 3 min in the cold. They were
washed once in 20 vol of the same buffer, and the superna-
tants were combined. The pellets were extracted with 10 vol
of 10 M urea in one-half vol of the above buffer (containing
1mM aprotinin, 1 mM PMSF, and 0.1 M leupeptin) for 15 min
at 4°C. The suspension was centrifuged for 5 min in an
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Eppendorf centrifuge in the cold, and the supernatant con-
taining the cytoskeletal proteins was removed. Under these
conditions extraction of cytoskeletal protein is quantitative.
Rabbit erythrocytes were hypotonically lysed in 20 vol of 5
mM sodium phosphate, pH 7.4, 1 mM EDTA, 1 mM
aprotinin, 1 mM PMSF, 0.1 mM leupeptin for 3 min on ice,
and the resulting ghosts were pelleted in a clinical centrifuge
for 5 min in the cold. They were washed three times with the
same buffer. The ghosts were dissolved in 10 vol of
NaDodSO4 sample buffer (125 mM Tris HCl, pH 6.8, 1%
NaDodSO4, 25 mM dithiothreitol).
Immunoprecipitation and NaDodSO4 Polyacrylamide Gel
Electrophoresis. For immunoprecipitation, extracts were di-
luted with 10-20 vol of 100 mM Tris HCl, pH 9.0, 200 mM
NaCl, 5 mM EIBTA, 5 mM EGTA, 5 mM dithiothreitol, 1%
Triton X-100, 0.1% NaDodSO4, 1 mM aprotinin, 0.1 mM
leupeptin, 1 mM PMSF. Chicken erythrocyte ankyrin (gob-
lin) antiserum (8) was added (10 ,ul per 1 Al of packed cells
extracted), and the immunoprecipitation was performed as
described (9) using Protein A-Agarose (Boehringer Mann-
heim). Precipitated proteins were eluted by heating in
NaDodSO4 sample buffer and loaded onto 12.5% NaDod-
S04/polyacrylamide gels (10) after centrifugation. For direct
analysis, extracts were diluted in NaDodSO4 sample buffer,
the NaDodSO4 concentration was adjusted to 1 or 2%, and
the samples were heated, centrifuged, and loaded onto the
gel. After electrophoresis, gels were either stained overnight
with Coomassie brilliant blue and destained, or directly
immersed into dimethylsulfoxide. They were then prepared
for fluorography as described by Bonner and Laskey (11).
Chloroform/Methanol Extraction and Alkaline Hydrolysis
of Bound Fatty Acids. For all treatments aliquots of the
extracts were lyophilized. One aliquot was extracted three
times with chloroform/methanol (2:1, vol/vol) and one time
each with chloroform/methanol (1:2, vol/vol), chloroform/
methanol/H20 (1:1:0.3, vol/vol), acetone (6), and then air-
dried. The other aliquots were dissolved in 0.2 M NaOH in
absolute methanol, 0.2 M KOH in absolute methanol, or 1 M
hydroxylamine in H20, pH 9.0 and incubated for 16 hr at 4°C.
They were then neutralized, frozen in liquid nitrogen and
lyophilized. All samples were redissolved in NaDodSO4
sample buffer for NaDodSO4 gel electrophoresis. These
treatments were also performed after separation of the
polypeptides by NaDodSO4 gel electrophoresis; gels were
immersed directly in (i) chloroform/methanol (2:1, vol/vol),
(it) 0.2 M KOH in absolute methanol, (iii) 0.2 M NaOH in
absolute methanol, or (iv) 1M hydroxylamine in H2O, pH 9.0.
The solutions were changed after 60 min. Treatments were
for 12 hr. Gels i-iii were washed for 30 min with H20 and
prepared for fluorography (see above), while the washing
step was omitted for gel iv.
RESULTS
Ankyrin is Fatty Acid Acylated. To examine the possibility
that proteins of the erythroid membrane skeleton may con-
tain bound long-chain fatty acids, we incubated erythroid
cells from 14-day-old chicken embryos with [3H]palmitic
acid. Preliminary experiments were carried out to optimize
the uptake of labeled fatty acid into the cells while simulta-
neously minimizing its conversion to amino acids. Under
these conditions [3H]palmitic acid is incorporated into a
number of proteins. A comparison of the urea-extracted
cytoskeletal polypeptides labeled with [3H]palmitic acid with
those labeled with a mixture of 14C-labeled amino acids
reveals a striking difference in the patterns of labeled
polypeptides, indicating the specificity of the fatty acid
labeling (Fig. LA). Most labeled polypeptides contain a low
level of [3H]palmitic acid (see Fig. 4 for a better visualization
of these polypeptides). However, a comparably high incor-
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FIG. 1. Analysis of amino acid- and palmitic acid-labeled avian
erythroid polypeptides. Erythroid cells from 14-day-old chicken
embryos were labeled with either 14C-labeled amino acids (lane 1) or
[3H]palmitic acid (ane 2) and urea extracts containing the cytoskel-
etal proteins were prepared. Polypeptides of total extracts (A) or
polypeptides immunoprecipitated from extracts with ankyrin anti-
serum (B) were separated on 12.5% NaDodSO4 polyacrylamide gels
and visualized by fluorography. Lanes 2 were exposed 2.5 times
longer than lanes 1. A, ankyrin; a, a-spectrin; ,, ,-spectrin.
poration of [3H]palmitic acid is apparent in a protein of the
cytoskeletal fraction that comigrates with ankyrin (Fig. LA).
To investigate whether this [3H]palmitic acid-labeled poly-
peptide is indeed ankyrin, we immunoprecipitated ankyrin
from solubilized cytoskeletons with ankyrin antibodies. Fig.
1B shows that the [3H]palmitic acid-labeled polypeptide is
immunoprecipitated with these antibodies. The ratio of
[3H]palmitic acid to 14C-labeled amino acid-labeled ankyrin is
the same in the immunoprecipitates and the total cytoskeletal
fractions (data not shown). This further substantiates that
ankyrin contributes to all or most of the radioactivity of the
3H-labeled band.
The fact that the 3H-labeled fatty acid remained associated
with ankyrin after Triton X-100 extraction and NaDodSO4
denaturation and gel electrophoresis was indicative of a tight
association between the two. To examine this further we
extracted gels containing [3H]palmitic acid- and 14C-labeled
amino acid-labeled samples of cytoskeletal fractions with
CHCl3/CH30H to remove noncovalently bound fatty acids.
As Fig. 2B shows, the majority of the ankyrin-bound
[3H]palmitic acid is resistant to extraction by CHCl3/CH30H
suggesting a covalent attachment to ankyrin. To exclude a
conversion of the palmitic acid into amino acids and their
subsequent incorporation into the polypeptide backbone we
attempted to release the bound fatty acid with hydroxyla-
mine. This treatment hydrolyzes esterified fatty acids. Fig.
2C (lane 2) shows that most of the 3H can be released from
ankyrin by this treatment. The decrease in label is not due to
the elution of proteins from the gel during the treatment as
indicated by the retention in the gel of the 14C-labeled amino
acid-labeled polypeptides (Fig. 2C, lane 1). Similar results
were obtained when the samples were treated with NH20H
or CHCl3/CH30H prior to electrophoresis (data not shown).
Methanolic KOH or methanolic NaOH treatment of gels or
of extracts prior to electrophoresis reduced the amount of
[3H]palmitic acid bound to ankyrin to a lesser degree than
hydroxylamine treatment (data not shown). Together these
observations strongly argue that the 3H associated with
ankyrin is not due to conversion of the [3H]palmitic acid to
3H-labeled amino acids and their subsequent incorporation
into the polypeptide backbone. They indicate that ankyrin
contains long-chain fatty acids, the majority of which are
bound covalently to the protein.
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FIG. 2. Extraction properties of the palmitic acid bound to
ankyrin. Urea extracts containing the cytoskeletal proteins were
prepared and separated on polyacrylamide gels as described in the
legend to Fig. 1. After completion of electrophoresis gels were
treated with (A) untreated control, (B) chloroform/methanol, (C)
hydroxylamine. Lanes 1, 14C-labeled amino acid-labeled polypep-
tides; lanes 2, [3H]palmitic acid-labeled polypeptides. Lanes 1 and 2
were exposed for different times. A, ankyrin; a, a-spectrin; 8,
P-spectrin.
Synthesis and Acylation of Ankyrin Are Not Coupled. To
determine whether the acylation of ankyrin required contin-
uous protein synthesis, one aliquot of chicken embryo
erythroid cells was incubated with '4C-labeled amino acids
and another with [3H]palmitic acid, in the presence or in the
absence of the protein synthesis inhibitor emetine. Emetine
was shown to be equally effective in both types of labeling
media. The 3H- and 14C-labeled cells were mixed after
labeling, lysed, and cytoskeletal fractions were prepared.
Fig. 3A shows the electropherograms of samples labeled
without emetine while Fig. 3B shows the corresponding
samples labeled in the presence of emetine. The patterns of
labeled polypeptides in the untreated samples largely reflect
the incorporation of amino acids (compare Fig. 1A, lane 1
with Fig. 3A, lane 2). As can be seen in Fig. 3B, emetine




FIG. 3. Palmitic acid- and amino acid-labeled polypeptides in
emetine-treated erythroid cells. Erythroid cells from 14-day-old
embryos were labeled separately with [3H]palmitic acid and 14C-
labeled amino acids in the presence or absence ofemetine. Detergent
and urea extracts were prepared after mixing amino acid- and
palmitic acid-labeled cells. A fluorograph of a NaDodSO4/poly-
acrylamide gel is shown containing the detergent extracts (lanes 1)
and the urea (cytoskeleton) extracts (lanes 2) from untreated cells (A)
or emetine-treated cells (B). A and B were exposed for different
times. A, ankyrin; a, a-spectrin; P, f3-spectrin.
drastically reduces labeling of most proteins. The resulting
pattern of labeled polypeptides is indistinguishable from the
polypeptide pattern obtained after labeling with [3H]palmitic
acid alone (compare Fig. LA, lane 2 with Fig. 3B, lane 2). The
most prominent polypeptide labeled is ankyrin, and the
intensity of its labeling is comparable to its labeling in
untreated cells. This result further argues that ankyrin is
labeled with [3H]palmitic acid and not label that has been
converted to amino acids. It also shows that fatty acid
acylation of ankyrin can occur in cells that do not synthesize
and assemble this protein. We conclude that acylation of
ankyrin is not necessarily coupled to its synthesis or assem-
bly. Rather it can occur on assembled ankyrin. The identity
of the other polypeptides that label with [3H]palmitic acid
(compare Fig. LA, lane 2 and Fig. 3B, lane 2) has not been
established.
Acylation of Ankyrin at Different Stages of Embryo Devel-
opment and in Adult Chicken and Rabbit Erythrocytes. To
determine whether the fatty acid acylation of ankyrin is
developmentally regulated we examined the incorporation of[3H]palmitic acid into ankyrin in erythroid cells from different
stages of chicken embryo development. Erythroid cells from
5-day-old embryos are mostly mitotic and belong to the
primitive series. Cells from 10-day-old embryos are mostly
postmitotic and are a mixture of definitive erythroblasts and
definitive erythrocytes, while those from 14-day-old embryos
are mostly definitive erythrocytes (12). Incorporation of
[3H]palmitic acid into ankyrin was detectable in cytoskeletal
fractions from 5-, 10- and 14-day-old cells suggesting that
fatty acid acylation of this protein occurs constitutively
throughout erythroid differentiation (Fig. 4, lanes 1-6). It
also appears to be independent of the erythroid cell lineage.
Incorporation of [3Hlpalmitic acid into ankyrin is evident also
in adult chicken (Fig. 4, lanes 7 and 8) and rabbit erythrocytes
(Fig. 5) under conditions where negligible incorporation of
14C-labeled amino acids into proteins is detected (Fig. 4, lane
7; Fig. 5, lane 1).
DISCUSSION
The results presented here indicate that the peripheral mem-
brane skeleton protein ankyrin is one of the most prominent
fatty acid acylated proteins after labeling of chicken or rabbit





FIG. 4. Palmitic acid incorporation into chicken erythroid mem-
brane-skeletal polypeptides during embryo development and in the
adult. Erythroid cells from 5-d (lanes 1 and 2), 10-d (lanes 3 and 4),
and 14-d embryos (lanes 5 and 6), erythrocytes from an adult chicken
(lanes 7 and 8) were labeled with 14Cdlabeled amino acids or
[3H]palmitic acid and fractionated. Urea extracts containing the
membrane-skeleton material from chicken- erythroid cells or eryth-
rocytes were separated on a 12.5% NaDodSO4/polyacrylamide gel
and visualized by fluorography. 14C-labeled amino acid-labeled
polypeptides, lanes 1, 3, 5, and 7; [3H]palmitic acid-labeled poly-
peptides, lanes 2, 4, 6, and 8. A, ankyrin.
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FIG. 5. Palmitic acid-labeled membrane-skeletal polypeptides of
rabbit erythrocytes. Adult rabbit erythrocytes were labeled with
'4C-labeled amino acids or [3H]palmitic acid and hypotonically lysed.
The resulting ghosts were dissolved in NaDodSO4 sample buffer and
separated on a 10% NaDodSO4/polyacrylamide gel. Under these
conditions mammalian ankyrin migrates between a- and P-spectrin;
it comigrates with a-spectrin in our 12.5% NaDodSO4/poly-
acrylamide gels. Fluorographs are shown of "4C-labeled amino
acid-labeled ghost polypeptides (lane 1) and [3H]palmitic acid-
labeled ghost polypeptides (lane 2). Separated polypeptides from
rabbit erythrocyte ghosts were also stained with Coomassie brilliant
blue (lane 3). A, ankyrin; a, a-spectrin; P, P-spectrin.
erythrocytes with [3H]palmitic acid. Palmitic acid is incor-
porated into ankyrin as fatty acid and not after conversion to
amino acids since the label is removed by hydroxylamine
treatment. Strong labeling with palmitic acid also occurs
when protein synthesis is negligible; this is evident in
erythroid cells after inhibition of protein synthesis with
emetine, as well as in adult chicken and rabbit erythrocytes
whose protein biosynthetic activity is naturally minimal. The
fatty acid is most likely bound covalently to the polypeptide
backbone as it is not extracted by Triton X-100, NaDodSO4,
and chloroform/methanol. Throughout this study we have
used [3H]palmitic acid for labeling; however, it remains to be
investigated which fatty acid(s) is (are) actually bound to
ankyrin.
We have not as yet determined the site(s) on ankyrin that
become(s) fatty acid acylated. The sensitivity of the binding
to hydroxylamine suggests that most of the fatty acid is
esterified to a thiol group or a hydroxy amino acid as has been
determined for transmembrane proteins such as vesicular
stomatitis and Sindbis virus glycoproteins (13, 14) or the
transferrin receptor (15). In these cases the site of the
polypeptide that is fatty acid acylated is in or close to the
highly hydrophobic domain that spans the lipid bilayer.
However, ankyrin behaves as a typical peripheral plasma
membrane protein as it is extracted from erythrocyte ghosts
with high salt or at high pH, but not at low ionic strength (10,
16-18). It is unlikely that ankyrin contains a hydrophobic
sequence that spans the lipid bilayer. Its acyl group(s)
probably is (are) bound to less hydrophobic sequences of the
polypeptide chain but this may increase the overall hydro-
phobicity of these domains. In this respect ankyrin is similar
to the viral transforming proteins Harvey sarcoma virus p21
(19) and simian virus 40 T antigen (20) that apparently lack
typical transmembrane sequences but also contain esterified
fatty acids. It is possible that a small amount of the incor-
porated fatty acid is bound to the NH2 terminus of ankyrin
through an amide linkage as has been described for myristic
acid attached to Rous sarcoma virus pp60S1 (19), calcineurin
B (21), or the cAMP-dependent protein kinase catalytic
subunit (22).
Studies on the vesicular stomatitis and Sindbis virus
glycoproteins indicate that the fatty acid modification occurs
after completion of synthesis of the polypeptides but before
the transport of these glycoproteins to the cell surface, most
likely at the transitional region of the endoplasmic reticulum
or in a cis-Golgi vesicle (6, 7). However, ankyrin, a peripheral
membrane protein (23), is most likely synthesized on free
polyribosomes, and there is no a priori reason to assume that
its biogenesis resembles that of a viral transmembrane
glycoprotein. From the evidence presented here it is apparent
that fatty acid acylation of ankyrin is not strictly coupled to
its synthesis or assembly onto the membrane skeleton. It can
occur at a comparable level in cells in which both processes
are minimal, namely in adult erythrocytes or in embryonic
erythroid cells treated with a protein synthesis inhibitor. In
these cells it is also unlikely that ankyrin is acylated at the
endoplasmic reticulum-Golgi complex after an association
with newly synthesized anion transporter molecules at intra-
cellular membranes. This is particularly evident in adult
erythrocytes that do not contain an extensive endoplasmic
reticulum-Golgi system. Thus, ankyrin can be acylated at a
site close to the plasma membrane after its assembly onto the
membrane skeleton. This implies that acyltransferases form-
ing ester on thioester linkages are active not only at the
endoplasmic reticulum-Golgi system where typical trans-
membrane proteins are acylated but also the cytoplasmic
surface of the plasma membrane. In the latter case acyltrans-
ferases may be responsible for the acylation of proteins that
bind directly from the cytoplasm to the plasma membrane. In
addition to ankyrin, possible examples of such proteins
include the T antigen of simian virus 40 (20) and p21 of
Harvey sarcoma virus (19), but also proteins which are
myristilated at the NH2 terminus [e.g., pp60SrC of Rous
sarcoma virus (19)]. Our results presented here indicate that
ankyrin can be acylated at the plasma membrane. It is
important to point out that they do not exclude an additional,
probably minor, acylation of ankyrin during any step of its
biogenesis prior to assembly.
The possible functions ofthe fatty acid acylation ofankyrin
presently are unknown. From the arguments discussed above
and the fact that the anion transporter provides the high-
affinity binding site for ankyrin at the plasma membrane, we
regard the possibility unlikely that fatty acid acylation drives
the assembly of ankyrin onto the plasma membrane. It seems
more likely that the acylation is related to a function of the
assembled ankyrin molecule. In this context it is important to
note that the bound fatty acid appears to turn over at a
substantially higher rate than the ankyrin polypeptide back-
bone as judged by its rapid incorporation into this protein in
adult erythrocytes and after inhibition of protein synthesis in
embryonic cells. This suggests that fatty acid acylation of
ankyrin is reversible and thus may serve to modulate the
function of ankyrin. Alternatively, it may indicate that only
a fraction of the ankyrin molecules are fatty acid acylated. A
reasonable assumption is that the fatty acid attached to
ankyrin allows for a direct interaction of this protein with the
lipid bilayer. Thus acylation of ankyrin may induce the
binding of a second site of the ankyrin molecule to the plasma
membrane and thereby serve to alter the strength and the
molecular geometry ofthe membrane cytoskeleton linkage. It
is also conceivable that the direct interaction of ankyrin with
the lipid bilayer may influence both the local lipid composi-
tion and organization of the bilayer. The constitutive incor-
poration of palmitic acid into ankyrin at all stages of chicken
embryo development examined, as well as in the adult
indicates that fatty acid acylation of ankyrin may be essential
to the organization or functioning of the membrane skeleton
irrespective of the erythroid lineage or the stage of differen-
tiation. A more general function of the acylation of ankyrin
also is indicated by the fact that this modification is not
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restricted to avian erythrocytes but can be demonstrated in
rabbit erythrocytes as well. Recent studies have shown that
ankyrin exists in various nonerythroid cells (24, 25). Analysis
ofa possible fatty acid acylation ofnonerythroid ankyrin may
further clarify the significance of this modification for the
function of ankyrin.
We thank Drs. Horst Hinssen, John Cox, and John Ngai for their
comments on the manuscript. This work was supported by grants
from the National Institutes of Health, National Science Foundation,
and Muscular Dystrophy Association. M.S. was also supported by a
Cancer Research Campaign International Fellowship awarded by the
International Union Against Cancer and a Senior Investigatorship of
the American Heart Association, Greater Los Angeles Affiliate.
1. Branton, D., Cohen, C. M. & Tyler, J. (1981) Cell 24, 24-32.
2. Bennett, V. (1985) Annu. Rev. Biochem. 54, 273-304.
3. Marchesi, V. T. (1985) Annu. Rev. Cell Biol. 1, 531-561.
4. Kennan, T. W., Heid, H. W., Stadler, J., Jarasch, E. D. &
Franke, W. W. (1982) Eur. J. Cell Biol. 26, 270-276.
5. Marinetti, G. V. & Cattieu, K. (1982) Biochim. Biophys. Acta
685, 109-116.
6. Schlesinger, M. J. (1983) Methods Enzymol. 96, 795-801.
7. Schmidt, M. F. G. (1983) Curr. Top. Microbiol. Immunol. 102,
101-129.
8. Nelson, W. J. & Lazarides, E. (1984) Proc. Natl. Acad. Sci.
USA 81, 3292-32%.
9. Staufenbiel, M. & Deppert, W. (1982) Exp. Cell Res. 138,
207-214.
10. Repasky, E. A., Granger, B. L. & Lazarides, E. (1981) Cell
29, 821-833.
11. Bonner, W. M. & Laskey, R. A. (1974) Eur. J. Biochem. 46,
83-88.
12. Bruns, G. A. P. & Ingram, V. H. (1973) Philos. Trans. R. Soc.
London Ser. B 266, 225-305.
13. Schmidt, M. F. G., Bracha, M. & Schlesinger, M. J. (1979)
Proc. Natl. Acad. Sci. USA 76, 1687-1691.
14. Schmidt, M. F. G. & Schlesinger, M. J. (1979) Cell 17,
813-819.
15. Omary, B. M. & Trowbridge, I. S. (1981) J. Biol. Chem. 256,
4715-4718.
16. Litman, D., Hsu, C. J. & Marchesi, V. T. (1980) J. Cell Sci.
42, 1-22.
17. Bennett, V. & Stenbuck, P. J. (1980) J. Biol. Chem. 255,
6424-6432.
18. Hargreaves, W. R., Giedd, K. N., Verkleij, A. & Branton, D.
(1980) J. Biol. Chem. 255, 11965-11972.
19. Sefton, B. M., Trowbridge, I. S. & Cooper, J. A. (1982) Cell
31, 465-474.
20. Klockmann, M. & Deppert, W. (1983) EMBO J. 2, 1151-1157.
21. Aitken, A., Cohen, P., Santikaru, S., Williams, D. H., Calder,
A. G., Smith, A. & Klee, C. B. (1982) FEBS Lett. 150,
314-317.
22. Carr, S. A., Biemann, K., Shoji, S., Parmelee, D. C. & Titani,
K. (1982) Proc. Natl. Acad. Sci. USA 79, 6128-6131.
23. Bennett, V. & Stenbuck, P. J. (1979) Nature (London) 280,
468-473.
24. Davis, J. Q. & Bennett, V. (1984) J. Biol. Chem. 259,
13550-13559.
25. Nelson, W. J. & Lazarides, E. (1984) Cell 39, 309-320.
Proc. Natl. Acad. Sci. USA 83 (1986)
